161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
Study suggests reinfections from the virus that causes COVID-19 likely have similar severity as original infection

Study suggests reinfections from the virus that causes COVID-19 likely have similar severity as original infection

byNational Institutes of HealthColorized scanning electron micrograph of a cell (red) infected with SARS-CoV-2 virus particles (blue), isolated from a patient sample. Credit: NIAIDUsing health d

Study suggests reinfections from the virus that causes COVID-19 likely have similar severity as original infection

byNational Institutes of HealthColorized scanning electron micrograph of a cell (red) infected with SARS-CoV-2 virus particles (blue), isolated from a patient sample. Credit: NIAIDUsing health d
Study identifies potential novel drug to treat tuberculosis

Study identifies potential novel drug to treat tuberculosis

byAmerican Society for MicrobiologyScanning electron micrograph ofMycobacterium tuberculosisbacteria, which cause TB. Credit: NIAIDA new study published inMicrobiology Spectrum

Study identifies potential novel drug to treat tuberculosis

byAmerican Society for MicrobiologyScanning electron micrograph ofMycobacterium tuberculosisbacteria, which cause TB. Credit: NIAIDA new study published inMicrobiology Spectrum
State-level COVID-19 restrictions helped save lives

State-level COVID-19 restrictions helped save lives

by Lori SolomonStringent state-level COVID-19 restrictions were associated with substantial decreases in pandemic mortality, according to a study published online July 26 inJAMA Health Forum.Chr

State-level COVID-19 restrictions helped save lives

by Lori SolomonStringent state-level COVID-19 restrictions were associated with substantial decreases in pandemic mortality, according to a study published online July 26 inJAMA Health Forum.Chr
T-cells with a license to kill viruses

T-cells with a license to kill viruses

byKyoto UniversityKilling of alveolar epithelial cells expressing viral protein by the killer T-cell medicine. Credit: KyotoU/Hiroshi KawamotoA research group led by Kyoto University has produce

T-cells with a license to kill viruses

byKyoto UniversityKilling of alveolar epithelial cells expressing viral protein by the killer T-cell medicine. Credit: KyotoU/Hiroshi KawamotoA research group led by Kyoto University has produce
Study demonstrates that mpox vaccine antibody responses wane within a year

Study demonstrates that mpox vaccine antibody responses wane within a year

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterMpox Virus Particle Colorized transmission electron micrograph of an mpox virus particle (yellow and red) found within an infected VERO

Study demonstrates that mpox vaccine antibody responses wane within a year

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterMpox Virus Particle Colorized transmission electron micrograph of an mpox virus particle (yellow and red) found within an infected VERO
Bartonella and Babesia co-infection detected in patients with chronic illness

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study
Researchers create new treatment and vaccine for flu and various coronaviruses

Researchers create new treatment and vaccine for flu and various coronaviruses

by Laurie Fickman,University of HoustonNanoSTING (and NanoSTING-SN) developed at UH to fight COVID and flu. Credit: University of HoustonA team of researchers, led by the University of Houston,

Researchers create new treatment and vaccine for flu and various coronaviruses

by Laurie Fickman,University of HoustonNanoSTING (and NanoSTING-SN) developed at UH to fight COVID and flu. Credit: University of HoustonA team of researchers, led by the University of Houston,
1999 to 2023 saw increase in heat-related mortality rates

1999 to 2023 saw increase in heat-related mortality rates

by Elana GotkineHeat-related mortality rates increased from 1999 to 2023 in the United States, according to a research letterpublishedonline Aug. 26 in theJournal of the American Med

1999 to 2023 saw increase in heat-related mortality rates

by Elana GotkineHeat-related mortality rates increased from 1999 to 2023 in the United States, according to a research letterpublishedonline Aug. 26 in theJournal of the American Med
Scientists developing a monoclonal antibody to neutralize Nipah virus one of the deadliest zoonotic pathogens

Scientists developing a monoclonal antibody to neutralize Nipah virus one of the deadliest zoonotic pathogens

by Delthia Ricks , Medical XpressGraph showing the percent change in weight from baseline in mice with Nipah virus disease, treated with either hu1F5, hu12B2, or both antibodies. Open symbols indicate

Scientists developing a monoclonal antibody to neutralize Nipah virus one of the deadliest zoonotic pathogens

by Delthia Ricks , Medical XpressGraph showing the percent change in weight from baseline in mice with Nipah virus disease, treated with either hu1F5, hu12B2, or both antibodies. Open symbols indicate
Promising tuberculosis therapy safe for patients with HIV, finds study

Promising tuberculosis therapy safe for patients with HIV, finds study

byTexas Biomedical Research InstituteResearchers compare the impacts of cART by itself versus cART plus the IDO inhibitor in lung tissue of nonhuman primates with both TB and SIV. Left: Followin

Promising tuberculosis therapy safe for patients with HIV, finds study

byTexas Biomedical Research InstituteResearchers compare the impacts of cART by itself versus cART plus the IDO inhibitor in lung tissue of nonhuman primates with both TB and SIV. Left: Followin
Shot of confidence: Building trust in vaccination programs

Shot of confidence: Building trust in vaccination programs

byOxford University PressCredit: Karolina Kaboompics from PexelsAnew paperin theJournal of Public Healthfinds that highlighting the harms of not getting vaccinated is a m

Shot of confidence: Building trust in vaccination programs

byOxford University PressCredit: Karolina Kaboompics from PexelsAnew paperin theJournal of Public Healthfinds that highlighting the harms of not getting vaccinated is a m
A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?

A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Pixabay/CC0 Public DomainAs a vaccine against Lyme disease enters late-stage clinical trials, scientists around the globe are already

A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Pixabay/CC0 Public DomainAs a vaccine against Lyme disease enters late-stage clinical trials, scientists around the globe are already